Trial Profile
Severe Decrease of Growth Velocity in Children With Anorexia Nervosa. Therapeutic Trial of Growth Hormone
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Growth disorders
- Focus Proof of concept; Therapeutic Use
- 07 Jun 2021 Status changed from active, no longer recruiting to completed.
- 27 Mar 2021 Primary endpoint (the growth-velocity) has been met as per results published in the Journal of Clinical Endocrinology and Metabolism
- 27 Mar 2021 Results published in the Journal of Clinical Endocrinology and Metabolism